Buchanan, R, Javitt, D, Marder, S, Schooler, N, Gold, J, McMahon, R, Heresco-Levy, U, Carpenter, WT (2007). The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. American Journal of Psychiatry
Carpenter, WT, Kirkpatrick, B (2015). Concepts and methods when considering negative symptoms course. Psychological Medicine. Published online 25 February 2015. doi:10.1017/S0033291715000069.
Dunayevich, E, Chen, CY, Marder, SR, Rabinowitz, J (2014). Restrictive symptomatic inclusion criteria create barriers to clinical research in schizophrenia negative symptoms: an analysis of the CATIE dataset. European Neuropsychopharmacology
Kirkpatrick, B, Fenton, WS, Carpenter, WT Jr, Marder, SR (2006). The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin
Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, Keefe, RS, Davis, SM, Davis, CE, Lebowitz, BD, Severe, J, Hsiao, JK (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine
Savill, M, Banks, C, Khanom, H, Priebe, S (2014). Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data. Psychological Medicine Published online 26 November 2014. doi:10.1017/S0033291714002712.